Healthtech Startups

Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases. Its CABA platform and lead CARTA program center on rese-cel, an investigational CD19-CAR T cell therapy being evaluated in trials across rheumatology, neurology, and dermatology.

2 investors

Caddie Health provides AI-powered medical billing software that recommends billing codes for visits, screens and verifies claims for errors before submission, and offers real-time dashboards to track billing performance. The product targets healthcare providers looking to reduce claim rejections and improve billing revenue.

2 investors

Cadence provides over-the-counter contraceptive products including morning-after pills, pregnancy tests, and UTI relief kits distributed through convenience stores. The company focuses on improving access to affordable reproductive health products without prescription or insurance requirements.

2 investors

Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression. The company was acquired by Novartis in 2021.

2 investors

Caeli Vascular develops a medical device platform for the treatment of venous thrombotic disease, specifically designed to remove blood clots in deep vein thrombosis cases. The company targets physicians and healthcare institutions seeking to improve patient outcomes in interventional vascular care.

2 investors

Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.

2 investors

CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry. The FDA-approved and UKCA-marked system is aimed at dental clinicians managing caries and erosion.

2 investors

Caliber offers a fitness, health, and wellness program built on research in training, nutrition, and habit formation, using a data-driven approach for users across different ages, experience levels, and equipment access. Founded in 2017, it serves individuals seeking to improve their fitness and overall wellness.

2 investors

Call9 provides emergency and palliative care to patients in skilled nursing facilities by combining onsite clinical care specialists with remote emergency medicine physicians who evaluate and treat patients via a proprietary platform, reducing response times from an average of 64 minutes to immediate care.

2 investors

Calliditas is a biopharmaceutical company developing and commercializing treatments for renal and other conditions, including TARPEYO/Nefecon/Kinpeygo (budesonide) for primary IgA nephropathy and NOX inhibitor candidates such as setanaxib for fibrotic diseases and cancer. It works with commercial partners including Everest Medicines and STADA to bring its therapies to markets such as the US, UK, EU, and China.

2 investors

Life Log Technology develops "Calomeal" (カロミル), a health-management app that uses AI and machine learning to recognize and quantify the nutritional content of meals for diet and nutrition tracking. The company collects dietary data to support disease prevention and healthy-lifespan extension, and conducts machine learning research and development in Japan.

2 investors

Cambridge Nutraceuticals develops and sells health supplements grounded in clinical research and scientific evidence, serving consumers seeking science-backed nutritional products. The company manufactures supplements with proven active ingredients and partners with leading academic research institutions.

2 investors

cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease). The company is advancing the drug into global Phase 2 clinical development.

2 investors

Osara Health (formerly CancerAid) provides digital support, education, and behavior change programs for people affected by cancer and their caregivers. The platform aims to improve clinical outcomes including quality of life, physical and mental health, and survival rates.

2 investors

Canid is a platform for pediatric and other medical practices that manages their entire vaccine program, including purchasing vaccine inventory, automating ordering, handling billing under the practice's contracts, VFC compliance, and state registry reporting. It integrates with EMR systems as an extension and adds population reporting and patient outreach tools.

2 investors

Canomiks is a life sciences company focused on developing treatments and research in diabetes, cardiovascular disease, and related areas, drawing on expertise in pharmacology, genomics, and bioinformatics.

2 investors

Canopy manufactures filtered showerheads designed to reduce chlorine and contaminants from shower water for improved skin and hair health. The products include fixed and handheld showerhead options with tool-free installation and proprietary tri-media filtration technology.

2 investors

Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.

2 investors

Cantourage imports and distributes medical cannabis sourced from cultivators worldwide to patients, pharmacies, and healthcare providers in Germany and across Europe. The company also develops cannabis-related pharmaceutical products and operates a platform connecting international growers with the European medical cannabis market.

2 investors

Canurta develops novel botanical drug candidates, starting with rare polyphenols, using an AI discovery engine that guides compound identification, optimization, GMP-compliant production, and blockchain-based traceability. The company targets disease pathways such as inflammation, oxidative stress, and neurodegeneration (including ALS) across its therapeutic pipeline.

2 investors

Capsa Healthcare designs integrated hardware and technology for pharmacy automation, medication management, and point-of-care workflows, serving hospitals, retail and institutional pharmacies, and other healthcare providers. Its products cover prescription dispensing, inventory management, controlled-medication handling, and clinical workstations and carts.

2 investors

Philips Capsule provides healthcare informatics solutions for hospitals and health systems, including medical device integration, system integration, cloud data storage and analytics, clinical surveillance, patient data management, and virtual care. Now part of the Philips Acute Care Informatics portfolio, its vendor-neutral platform connects live data from over 1,200 medical devices to more than 100 clinical systems.

2 investors

CAPS operates a clinic chain management business, offers corporate health management support services, runs fitness facilities, and provides health education programs in Japan.

2 investors

CapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies. The company applies cell biology and computational methods to cell identity for research, testing, and regenerative medicine.

2 investors